首页> 外文会议>Annual meeting exposition of the Controlled Release Society >Effect of different parameters on characteristics of doxorubicin loaded PCLF nanoparticles and evaluation of lymphatic uptake by in vivo imaging
【24h】

Effect of different parameters on characteristics of doxorubicin loaded PCLF nanoparticles and evaluation of lymphatic uptake by in vivo imaging

机译:不同参数对阿霉素负载的PCLF纳米颗粒特性的影响以及体内成像评估淋巴吸收

获取原文
获取外文期刊封面目录资料

摘要

In this study poly(caprolactone fumarate) (PCLF) copolymer has been used to prepare nanoparticles (NPs). Degradation of PCLF against time was evaluated in different mediums. NPs were prepared via two different methods; microemulsion polymerization and nanoprecipitation method. Effect of various factors such as copolymer molecular weight (M_w), PVA M_w, type of solvent and, solvent volume ratio (S/NS) and drug concentration on NP size, stability and drug loading was determined. PCLF 1250 was chosen as more suitable copolymer for its slightly higher loading of hydrophilic drug compared to PCLF 530 and also for making smaller NPs in comparison with the PCLF 2000. Drug release was also investigated in PBS. The optimum formulation was injected to the mouse for in vivo imaging to understand the possibility of delivering PCLF NPs to the lymphatic tissue. The hydrophobicity of the copolymer could help NPs accumulate into lymphatic nodes more than other tissues.
机译:在这项研究中,聚己内酯富马酸酯(PCLF)共聚物已用于制备纳米颗粒(NPs)。在不同的介质中评估了PCLF随时间的降解。 NPs是通过两种不同的方法制备的。微乳液聚合和纳米沉淀法。确定了各种因素的影响,例如共聚物分子量(M_w),PVA M_w,溶剂和溶剂的类型,溶剂体积比(S / NS)和药物浓度对NP大小,稳定性和载药量的影响。与PCLF 530相比,PCLF 1250被选为更合适的共聚物,因为其亲水性药物的载量略高于PCLF 530,并且与PCLF 2000相比,还可以制备更小的NP。还研究了在PBS中的药物释放。将最佳制剂注射到小鼠体内进行成像,以了解将PCLF NP递送至淋巴组织的可能性。共聚物的疏水性可以帮助NPs比其他组织更多地积累到淋巴结中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号